HCWB HCW Biologics Inc
Company Analysis
Latest News
🟢 HCW Biologics is trading 6.77% up in after-hours trading after Akron Biotech distribution deal
HCW Biologics is trading 6.77% up at $2.68 in after-hours trading after announcing an exclusive distribution agreement with Akron Biotech for HCW11-006. - The...
🔴 HCW Biologics is trading 14.97% down today; no verified catalyst identified
HCW Biologics is trading 14.97% down now at $2.50 after no verified September 8, 2026 company-specific catalyst was identified. - The latest confirmed...
🔴 HCW Biologics is trading 10.47% down in pre-market — no verified company-specific catalyst identified
HCW Biologics is trading 10.47% down now at $2.63 after no verified September 8, 2026 company-specific catalyst was identified. - The latest confirmed...
🔴 HCW Biologics is trading 7.13% down in pre-market as no verified catalyst was identified
HCW Biologics is trading 7.13% down at $2.73 with no verified September 8, 2026 company-specific catalyst identified. - The latest confirmed announcement was...
🟢 HCW Biologics is trading 14.56% up in pre-market; no verified company-specific catalyst identified
HCW Biologics is trading at $3.37, up +14.56%, with no verified September 8, 2026 company-specific catalyst identified. • The latest confirmed announcement...
🔴 HCW Biologics is trading 12.4% down today with no clear negative catalyst identified
HCW Biologics is trading 12.4% down now at $2.94, with no clear company-specific negative catalyst identified for September 3, 2026. - The decline continues a...
🔴 HCW Biologics is trading 5.81% down today — no company-specific catalyst identified
HCW Biologics is trading at $3.16, down 5.81% during the open session, with no new negative company-specific catalyst or explicit explanation identified for...
🔴 HCW Biologics is trading 5.81% down in after-hours trading — decline unexplained
HCW Biologics is trading at $3.16 (-5.81%) after the September 2, 2026 news announcement, though the after-hours decline is unexplained. - It closed at $3.35...
🟢 HCW Biologics is trading 6.67% up today as XBI gains 2.75%
HCW Biologics is trading at $3.68 (+6.67%) on September 2, 2026, as broader biotechnology sentiment remains supportive, with XBI up 2.75%. - No newly reported...
🟢 HCW Biologics is trading 7.55% up in pre-market with no fresh company-specific catalyst identified
HCW Biologics is trading 7.55% up now at $3.71 after a strong multi-session rally, though no definitive catalyst has been identified for September 2, 2026. -...
🔴 HCW Biologics is trading 5% down today after profit-taking following a sharp multi-session rally
HCW Biologics is trading 5.01% down now at $3.41, with apparent profit-taking adding pressure after a sharp multi-session rally. - Shares rose from $2.18 on...
🔴 HCW Biologics is trading 5.3% down in pre-market amid apparent profit-taking after consecutive gains
HCW Biologics is trading at $3.40, down 5.29% in pre-market amid apparent profit-taking after a sharp multi-session rally. - No new company-specific...
🔴 HCW Biologics is trading 7% down in after-hours trading after sharp multi-session rally
HCW Biologics is trading 6.96% down at $3.34 in after-hours trading, possibly reflecting profit-taking following a sharp multi-session rally. - No...
🔴 HCW Biologics is trading 5.25% down today after a sharp multi-session rally
HCW Biologics is trading 5.25% down at $3.25 after a sharp multi-session rally. - Shares gained 17.41% on August 27 and 8.20% on August 28. - No...
🔴 HCW Biologics is trading 6.4% down in pre-market after sharp multi-session rally
HCW Biologics is trading 6.4% down in pre-market at $3.21 after a sharp multi-session rally. - Shares gained 17.41% on August 27 and 8.20% on August 28. - No...
🟢 HCW Biologics is trading 6.17% up today despite no confirmed explanation
HCW Biologics is trading 6.17% up at $3.37, extending a sharp multi-session advance with no new company-specific announcement dated August 28, 2026 clearly...
🔴 HCW Biologics falls 5.4% — Biotech Sector Declines Amid Fed Rate Hike Fears
With Biotech (XBI) down 2.3%, this looks like a sector-led move rather than a company-specific surprise. The biotech sector, as measured by the XBI ETF, fell...
🔴 HCW Biologics is trading 6.5% down in after-hours trading — no confirmed catalyst identified
HCW Biologics is trading 6.5% down in after-hours trading at $2.96, with no confirmed catalyst identified. - It closed at $3.17 on August 27, 2026, after a...
🟢 HCW Biologics is trading 11.11% up today amid broader risk-on sentiment
HCW Biologics is trading 11.11% up now at $3.00, with the move appearing aligned with broader risk-on sentiment; this is a market-driven explanation, not a...
🟢 HCW Biologics is trading 5.9% up today amid broader risk-on momentum
HCW Biologics is trading 5.9% up now at $2.86 as broader risk-on sentiment supports higher-beta growth stocks. - No new company-specific announcement dated...